Publications

Project

The Childhood and Adolescent Migraine Prevention (CHAMP) Study: ‘What Do We Do Now?’

Powers SW, Hershey AD, and Coffey CS on behalf of the CHAMP Study Group

Headache. 2017 February; 57 (2) 180-183.

PubMed:

National Institutes of Health-Sponsored Clinical Islet Transplantation Consortium Phase 3 Trial: Manufacture of a Complex Cellular Product at Eight Processing Facilities

Ricordi C, Goldstein JS, Balamurugan AN, Szot GL, Kin T, Liu C, Czarniecki CW, Barbaro B, Bridges ND, Cano J, Clarke WR, Eggerman TL, Hunsicker LG, Kaufman DB, Khan A, Lafontant DE, Linetsky E, Luo X, Markmann JF, Naji A, Korsgren O, Oberholzer J, Turgeon NA, Brandhorst D, Chen X, Friberg AS, Lei J, Wang LJ, Wilhelm JJ, Willits J, Zhang X, Hering BJ, Posselt AM, Stock PG, Shapiro AM, Chen X.

Diabetes. 2016 November; 65 (11) 3418-28.

PubMed:

PMC5079635

Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for Neuroprotection

Lyden P, Weymer S, Coffey C, Cudkowicz M, Berg S, O’Brien S, Fisher M, Haley EC, Khatri P, Saver J, Levine S, Levy H, Rymer M, Wechsler L, Jadhav A, McNeil E, Waddy S, and Pryor K

Stroke. 2016 November 1; 47 (12) 2979-2985.

PubMed:

PMC5134840

Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap

Anderegg MD, Gums TH, Uribe L, Coffey CS, James PA, & Carter BL

Hypertension. 2016 September 6; 68 (5) 1314-1320.

PubMed:

PMC5063695

Design, Rationale, and Baseline Characteristics of the Randomized Double-Blind Phase II Clinical Trial of Ibudilast in Progressive Multiple Sclerosis

Fox RJ, Coffey CS, Cudkowicz ME, Gleason T, Goodman, A, Klawiter EC, Matsuda K, McGovern M, Conwit R, Naismith R, Ashokkumar A, Bermel R, Ecklund D, Koepp M, Long J, Natarajan S, Ramachandran S, Skaramagas T, Thornell B, Yankey J, Agius M, Bashir K, Cohen B, Coyle P, Delgado S, Dewitt D, Flores A, Giesser B, Goldman M, Jubelt B, Lava N, Lynch S, Miravalle A, Moses H, Ontaneda D, Perumal J, Racke M, Repovic P, Riley C, Severson C, Shinnar S, Suski V, WeinstockGutman B, Yadav V, & Zabeta A

Contemporary Clinical Trials. 2016 August 10; 50 166-177.

PubMed:

PMC5035622

CSF Biomarkers Associated with Disease Heterogeneity in Early Parkinson’s Disease: The Parkinson’s Progression Marker’s Initiative Study

Kang JH, Mollenhauer B, Coffey CS, Toledo JB, Weintraub D, Galasko DR, Irwin DJ, Van Deerlin V, Chen-Plotkin AS, Caspell-Garcia C, Waligorska T, Taylor P, Shah N, Pan S, Zero P, Frasier M, Marek K, Keiburtz K, Jennings D, Tanner CM, Simuni T, Singleton A, Toga AW, Chowdhury S, Trojanowski JQ, & Shaw LM on behalf of the Parkinson’s Progression Markers Initiative

Acta Neuropathologica. 2016; 131 (6) 935-949.

Ethical Considerations in Novel Adaptive Design Clinical Trials

Laage T, Loewy J, Menon S, Miller E, Pulkstenis E, Kan-Dobrosky N, & Coffey C

Therapeutic Innovation & Regulatory Science. 2016; 51 (2) 190-199.

Phase 3 Trial of Transplantation of Human Islets in Type 1 Diabetes Complicated by Severe Hypoglycemia

Hering BJ, Clarke WR, Bridges ND, Eggerman TL, Alejandro R, Bellin MD, Chaloner K, Czarniecki CW, Goldstein JS, Hunsicker LG, Kaufman DB, Korsgren O, Larsen CP, Luo X, Markmann JF, Naji A, Oberholzer J, Posselt AM, Rickels MR, Ricordi C, Robien MA, Senior PA, Shapiro AM, Stock PG, Turgeon NA, Clinical Islet Transplantation Consortium.

Diabetes Care. 2016 July; 39 (7) 1230-40.

PubMed:

PMC5317236